Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Developmental toxicity / teratogenicity

Currently viewing:

Administrative data

Endpoint:
developmental toxicity
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1976.
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1977
Report date:
1976

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 414 (Prenatal Developmental Toxicity Study)
Deviations:
yes
Remarks:
only one dose tested, no information on analytical verification of concentration.
GLP compliance:
no
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Diosmin
EC Number:
208-289-7
EC Name:
Diosmin
Cas Number:
520-27-4
Molecular formula:
C28H32O15
IUPAC Name:
diosmin
Test material form:
not specified
Specific details on test material used for the study:
- Source: diosmin, sodium salt.

Test animals

Species:
mouse
Strain:
ICR
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Average initial weight: 29 g.

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on exposure:
PREPARATION OF DOSING SOLUTIONS: The sodium salt of diosmin was dissolved in water and given by esophageal tube in a daily dose of 50 mg/kg from the 4th to the 12th post-coital days.
Analytical verification of doses or concentrations:
no
Details on mating procedure:
- Impregnation procedure: cohoused
- Proof of pregnancy: vaginal plug referred to as day 0 of pregnancy
Duration of treatment / exposure:
8 days.
Frequency of treatment:
Daily
Duration of test:
Up to 20 days after conception (group 2).
Doses / concentrations
Dose / conc.:
50 mg/kg bw/day (nominal)
No. of animals per sex per dose:
4 groups (2 controls and 2 dosed) of 11 females each.
Control animals:
yes, concurrent no treatment

Examinations

Maternal examinations:
CAGE SIDE OBSERVATIONS: No data

DETAILED CLINICAL OBSERVATIONS: Yes

BODY WEIGHT: Yes

WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No data

POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation day # 19 (group 1)
- Sacrifice (group 2): On the 0, 6, 13 or 20th day after birth the mother animals and offspring were sacrificed.
- Organs examined: in the offspring the following organs were macroscopically and histologically examined: heart, liver, spleen and kidneys. In the mother animals the right and left uterine horns were examined with respect to sites of implantation and absorption.
Ovaries and uterine content:
The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: No data
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes
- Number of late resorptions: Yes
Fetal examinations:
- External examinations: Yes. Sex, weight and length were determined.
- Soft tissue examinations: The foetuses were examined with respect to palatal clefts and malformations of the extremities and tail.
- Skeletal examinations: Yes. The skeletons were examined, in particular with respect to vertebral block or cleft formation, number, length, possible fusions and ossifications, form and number of bones.
- Head examinations: No data

- In another group, delivery was by spontaneous birth. The foetuses were macroscopically examined with respect to palatal clefts and malformations of extremities and the tail. Sex, weight and lenght of the foetuses were determined. The development of the animals was followed (openning of the eyes, growth of hair, etc.).

Results and discussion

Results: maternal animals

General toxicity (maternal animals)

Clinical signs:
no effects observed
Dermal irritation (if dermal study):
not examined
Mortality:
no mortality observed
Body weight and weight changes:
not specified
Food consumption and compound intake (if feeding study):
not examined
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
not specified
Ophthalmological findings:
not examined
Haematological findings:
not examined
Clinical biochemistry findings:
not examined
Urinalysis findings:
not examined
Behaviour (functional findings):
no effects observed
Immunological findings:
not examined
Organ weight findings including organ / body weight ratios:
not specified
Gross pathological findings:
no effects observed
Neuropathological findings:
not examined
Histopathological findings: non-neoplastic:
not specified
Histopathological findings: neoplastic:
not specified
Other effects:
no effects observed

Maternal developmental toxicity

Number of abortions:
no effects observed
Pre- and post-implantation loss:
no effects observed
Total litter losses by resorption:
not specified
Early or late resorptions:
no effects observed
Dead fetuses:
no effects observed
Changes in pregnancy duration:
not specified
Description (incidence and severity):
Migrated Data from removed field(s)
Field "Effects on pregnancy duration" (Path: ENDPOINT_STUDY_RECORD.DevelopmentalToxicityTeratogenicity.ResultsAndDiscussion.ResultsMaternalAnimals.MaternalDevelopmentalToxicity.EffectsOnPregnancyDuration): not specified
Changes in number of pregnant:
not specified
Other effects:
no effects observed
Details on maternal toxic effects:
No maternal toxic effects were observed.

Effect levels (maternal animals)

Key result
Dose descriptor:
NOAEL
Effect level:
> 50 mg/kg bw (total dose)
Based on:
test mat.
Basis for effect level:
other: maternal toxicity
Remarks on result:
not determinable due to absence of adverse toxic effects

Maternal abnormalities

Key result
Abnormalities:
no effects observed

Results (fetuses)

Fetal body weight changes:
no effects observed
Description (incidence and severity):
Migrated Data from removed field(s)
Field "Fetal/pup body weight changes" (Path: ENDPOINT_STUDY_RECORD.DevelopmentalToxicityTeratogenicity.ResultsAndDiscussion.ResultsFetuses.FetalPupBodyWeightChanges): no effects observed
Field "Description (incidence and severity)" (Path: ENDPOINT_STUDY_RECORD.DevelopmentalToxicityTeratogenicity.ResultsAndDiscussion.ResultsFetuses.DescriptionIncidenceAndSeverityFetalPupBodyWeightChanges): The average weight was of 1.4 g in controls and 1.25 g in treated animals .
Reduction in number of live offspring:
no effects observed
Changes in sex ratio:
not specified
Changes in litter size and weights:
not specified
Description (incidence and severity):
The mean number of animals per litter was 12.3 in the control group and 11.5 in the treated group.
Changes in postnatal survival:
no effects observed
External malformations:
no effects observed
Skeletal malformations:
no effects observed
Description (incidence and severity):
Neither in the control nor in the diosmin group did the inspection of 126 skeletal preparations each show any pathological findings.
Visceral malformations:
no effects observed
Other effects:
no effects observed
Details on embryotoxic / teratogenic effects:
Assessment of the foetuses did not reveal any difference between the two experimental groups and the control.

Effect levels (fetuses)

Key result
Dose descriptor:
NOAEL
Effect level:
>= 50 mg/kg bw (total dose)
Based on:
test mat.
Sex:
not specified
Basis for effect level:
other: teratogenicity

Fetal abnormalities

Key result
Abnormalities:
no effects observed

Overall developmental toxicity

Key result
Developmental effects observed:
no

Any other information on results incl. tables

- After laparotomy, the mean number of animals per litter was 12.3 in the control group and 11.5 in the diosmin treated group. The average weight was of 1.4 g. in controls and 1.25g. in diosmin treated animals. Neither in the control nor in the diosmin group did the inspection of 126 skeletal preparations each show any pathological findings.

- After spontaneous delivery, the average number of animals per litter was 11.35 and 11.4 (respectively in the control and diosmin group). Postnatal mortality (20-day period) was of 19 and 26%, respectively. Weight gain, length, development, gross behavior, growth of hair and opening of the eyes were identical in the two groups. Organ weights, macroscopical and histological findings did not differ significantly in the diosmin treated animals from the control ones.

Table 1. Experimental results on mice.

11 mother animals each

Sites of implantation

Number of fetuses

Absorptions

Malformations

Underdeveloped

Controls

152

Live

125

17

0

26

Dead

10

Diosmin

143

Live

126

17

0

1

Dead

0

 

Applicant's summary and conclusion

Conclusions:
Under test conditions, the test item has no teratogenic effects. The NOAEL for developmental toxicity in mice is ≥ 50mg/kg bw/d.
Executive summary:

A study was conducted to assess the teratogenicity potential of the sodium salt of diosmin, by a method similar to OECD 414 (no GLP). Two groups of 11 female ICR mice each were orally administered 50 mg/kg bw/d of test item from the 4th to the 12th post-coital days. Two further control groups were run in parallel. In one of the groups, the foetuses were delivered by laparotomy on the 19th day after conception and the sites of implantation and absorption in both horns of the uterus were determined. The foetuses were examined with respect to palatal clefts and malformations of the extremities and tail; the sex weight and length were determined; then, they were killed and their skeletons stained and examined. In the other treated group, delivery was by spontaneous birth and the development of the animals was followed. There was no reduction in number of foetuses, no increase in absorption sites, no significant alteration of rate of malformations, postnatal morbility, weight gain and development or histology of several organs. Thus, it was concluded that the test item does not have any teratogenic effects. The NOAEL for developmental toxicity of the test item in mice is greater than 50 mg/kg bw/d.